8-K
filed January 24, 2024, 6:59 PM ET
ticker ELV
CIK 0001156039
earnings
confidence high
sentiment positive
materiality 0.80
Elevance Health Q4 adj EPS $5.62 (+15.2% YoY); FY 2024 outlook above $37.10
Elevance Health, Inc.
2023-FY EPS reported
$25.22
revenue$171,340,000,000
- Q4 GAAP diluted EPS $3.63 (+1.1% YoY); adjusted diluted EPS $5.62 (+15.2% YoY).
- Q4 operating revenue $42.5B, up 7% YoY; full-year revenue $170.2B, up 9.3% YoY.
- FY 2024 guidance: GAAP EPS >$34.29, adjusted EPS >$37.10; quarterly dividend raised 10.1% to $1.63.
- Medical membership 47.0M, down 570k YoY from Medicaid redeterminations; Health Benefits operating gain +14% for the year.
- Operating cash flow $8.1B in 2023; repurchased 5.8M shares for $2.7B during the year.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Elevance Health, Inc. reported FY 2023 results: revenue $170 billion, EPS $25.22.
- Period
- FY 2023
- Revenue
- $170 billion
- EPS
- $25.22
- Result
- reported results
Exact text from the filing
FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022 • 4Q 2023 GAAP diluted EPS 1 of $3.63, up 1.1% from 4Q 2022 and adjusted diluted EPS 2 of $5.62, up 15.2%; FY 2023 GAAP diluted EPS of $25.22, up 3.9% from FY 2022
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Elevance Health, Inc. reported Q4 2023 results: revenue $42.5 billion, EPS $3.63.
- Period
- Q4 2023
- Revenue
- $42.5 billion
- EPS
- $3.63
- Result
- reported results
Exact text from the filing
4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022 • 4Q 2023 GAAP diluted EPS 1 of $3.63, up 1.1% from 4Q 2022
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Elevance Health, Inc. reported FY 2024 results: EPS greater than $34.29. Guidance initiated.
- Period
- FY 2024
- EPS
- greater than $34.29
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Projected FY 2024 GAAP diluted EPS and adjusted diluted EPS 2 of greater than $34.29 and $37.10 per share, respectively
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.